Evaxion Biotech A/S ADR (EVAX) Stock Price, Quote & News

Company Profile

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03, DNA-based cancer vaccine for the treatment of solid tumors; and EVX-04, a therapeutic cancer vaccine candidate, which is in phase 1 trial for acute myeloid leukemia. Its programs also include vaccines that are in pre-clinical stage, which includes EVX-B1, a m...

Industry: Biotechnology

Sector: Healthcare

Phone: 45 53 53 18 50

Website: evaxion.ai

Address:

Dr. Neergaards Vej, 5th Floor, Horsholm, Denmark

vcaelum Aug. 19 at 12:12 PM

$ARCT I'm in 12.3 hard SL 10.5, riding up $MRNA $EVAX momentum

0 · Reply

Mden Aug. 19 at 12:03 PM

$EVAX it will move up

0 · Reply

ChubbyPanda Aug. 19 at 11:52 AM

$EVAX I think I'm gonna give this the day and see what happens. If I were them I would put together a PR about something fluffily positive and get the price up to use their ATM.

0 · Reply

asbpame Aug. 19 at 11:49 AM

$EVAX poker games to grab shares

0 · Reply

Biotech_Pharma_Investor Aug. 19 at 11:48 AM

$EVAX cant even get a decent sympathy run? lol $MRNA validated personalized cancer vaccine in a ph3. EVAX has a ready to partner personalized cancer vaccine and a pipeline of cancer vaccines + infectious diseases vaccines + Merck partnership. And trading at a $25M valuation...

0 · Reply

ChubbyPanda Aug. 19 at 11:45 AM

$EVAX yeah, this really sucked. But I do feel like this is a serious indication that they are undervalued right now. Granted, they are only in phase 2, but any positive results from there could really get it going. Today it seems to be crap though.

0 · Reply

NoNoNoNoNoNoYesNo Aug. 19 at 11:44 AM

$EVAX well, that sucked. Was thinking we had a runner on their cancer vaccine news, but as usual, shorts got the best of it.

1 · Reply

Naaman12 Aug. 19 at 11:29 AM

$EVAX All on 5000 shares on avg 3.51 $PFSA $AZI

3 · Reply

ItTakesItAll Aug. 19 at 11:28 AM

$EVAX 10% 4.11-4.52🎈 back to 2.76 and now 3.20s hehehe...DT is fast and furious got to be ultra fast and focus.....

0 · Reply

Aatrader2475 Aug. 19 at 11:25 AM

$EVAX that has a good look to it 👀

0 · Reply

Evaxion expands and refocuses R&D pipeline with EVX-05, an AI-designed off-the-shelf brain cancer vaccine program

Aug 14, 2026, 8:00 AM EDT - 5 days ago

Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026

2026-08-10T14:15:17.000Z - 8 days ago

Merck discloses 1.21M share holding in Evaxion Biotech

MRK

2026-07-17T11:40:27.000Z - 4 weeks ago

Evaxion Biotech to present EVX-01 clinical efficacy data at ESMO

Jul 17, 2026, 7:15 AM EDT - 4 weeks ago

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

2026-07-12T13:45:04.000Z - 5 weeks ago

Evaxion Biotech presents new data on EVX-V1

Jul 12, 2026, 9:30 AM EDT - 5 weeks ago

Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

Jul 1, 2026, 8:00 AM EDT - 7 weeks ago

Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop

Jun 12, 2026, 3:00 AM EDT - 2 months ago

Evaxion receives Prix Galien UK Award for Best digital health solution

Jun 11, 2026, 2:00 AM EDT - 2 months ago

Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia

May 12, 2026, 9:30 AM EDT - 3 months ago

Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 3 months ago

Evaxion Slides: Q1 2026

May 7, 2026, 7:30 AM EDT - 3 months ago

Evaxion announces business update and first quarter 2026 financial results

May 4, 2026, 8:00 AM EDT - 3 months ago

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

2026-04-27T16:25:27.000Z - 4 months ago

Evaxion Biotech management to meet with Maxim

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

2026-04-17T19:15:15.000Z - 4 months ago

Evaxion says EVX-01 demonstrates 86% vaccine target precision in trial

Apr 17, 2026, 3:10 PM EDT - 4 months ago

Evaxion's AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

2026-04-17T19:05:59.000Z - 4 months ago

Evaxion Biotech announces new data to be presented at AACR meeting

Apr 16, 2026, 11:30 AM EDT - 4 months ago

Evaxion concludes Annual General Meeting

2026-04-07T12:55:09.000Z - 4 months ago

Evaxion Biotech reports last patient visit in one-year extension of EVX-01 trial

MRK

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress

Mar 19, 2026, 9:00 AM EDT - 5 months ago

Notice to convene Evaxion's Annual General Meeting

2026-03-09T20:11:13.000Z - 5 months ago